Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Precision Health Database


Precision Health Database|Search|PHGKB

Heart, Lung, Blood and Sleep Disorders

Last data update: Sep 22, 2023. (Total: 61629 Documents since 2012)
   dataset      
Filtered By:

Previous    

Records 1 - 30 (of 646 Records)

Next

Query Trace:
Gene therapy for Hemoglobinopathies.
Maria Rosa Lidonnici et al. Hum Gene Ther 2023
Preimplantation genetic testing for sickle cell disease: a cost-effectiveness analysis.
Joshua C Combs et al. F S Rep 2023 4(3) 300-307
Pregnant and Living with Sickle Cell Disease: A Push for Better Outcomes
NIH, September 2023
Evaluation of newborn screening in the state of Mato Grosso from 2005 to 2019.
Roseli Divino Costa et al. Rev Paul Pediatr 2023 42e2022161
CRISPR-Cas9 Editing of the HBG1 and HBG2 Promoters to Treat Sickle Cell Disease.
Akshay Sharma et al. N Engl J Med 2023 389(9) 820-832
Newborn screening for sickle cell disease in Butembo and Beni: a pilot experience in a highland region of the Democratic Republic of Congo.
Mupenzi Mumbere et al. Pan Afr Med J 2023 4556
Sickle cell disease in Ontario, Canada: an epidemiologic profile based on health administrative data.
Jacob Pendergrast et al. CMAJ Open 2023 11(4) E725-E733
Genetic counseling in sickle cell disease: Insights from the Indian tribal population.
Pooja Aggarwal et al. J Community Genet 2023
Barriers and Facilitators of Premarital Genetic Counseling for Sickle Cell Disease in Northern Nigeria.
Aisha A Galadanci et al. J Pediatr Hematol Oncol 2023 45(6) e716-e722
Base-edited gene therapies ‘may be superior’ for sickle cell disease
Healio, July 2023
Sickle cell disease landscape and challenges in the EU: the ERN-EuroBloodNet perspective.
María Del Mar Mañú Pereira et al. Lancet Haematol 2023
Sickle cell disease in the Caribbean: progress in newborn screening, clinical care, and research through collaboration.
Jennifer Knight-Madden et al. Lancet Haematol 2023
Defining global strategies to improve outcomes in sickle cell disease: a Lancet Haematology Commission.
Frédéric B Piel et al. Lancet Haematol 2023
The Importance of Patient-Doctor Relationships With Sickle Cell Disease
L Poret, WebMD, July 2023
Global, regional, and national prevalence and mortality burden of sickle cell disease, 2000-2021: a systematic analysis from the Global Burden of Disease Study 2021.
et al. Lancet Haematol 2023
Social determinants of health: the next frontier for improving care and outcomes in sickle cell disease
JS Porter et al, Lancet Heamtology, July 2023
The Lancet Haematology Commission on sickle cell disease: key recommendations
The Lancet Haematology Commission on sickle cell disease: Lancet Hematology, July 2023
Ending the burden of sickle cell disease in Africa
MR Motti et al, Lancet Hematology, July 2023
School and Sickle Cell Disease: Lessons I Had to Unlearn
DN Wilson, WebMD, July 2023
Clinical Profiles of Children With Sickle Cell Anaemia Presenting With Acute Clinical Events: A Single-Center Study.
Anwesha Singh et al. Cureus 2023 15(5) e39008
Evaluating the Discriminatory Ability of the Sickle Cell Data Collection Program's Administrative Claims Case Definition in Identifying Adults With Sickle Cell Disease: Validation Study.
Ashima Singh et al. JMIR Public Health Surveill 2023 9e42816
The Role of Hyposthenuria in Enuresis Among Paediatric Patients With Sickle Cell Disease.
Jasim N Al-Asadi et al. Sultan Qaboos Univ Med J 2023 23(2) 206-211
Potent and uniform fetal hemoglobin induction via base editing.
Thiyagaraj Mayuranathan et al. Nat Genet 2023
Base editing shows potential superiority for curing sickle cell disease
Medical XPress, June 29, 2023
[Place of screening and genetic counseling in sickle cell disease].
Assa Niakaté et al. Rev Prat 2023 73(5) 531-534
Study provides a more complete picture of sickle cell disease mortality burden
L Ramsey, News Medical, June 2023
CRISPR Therapy Exceeds Targets in Thalassemia, Sickle Cell Disease
M Basset, Medpage today, June 13, 2023
A Critical Review of Sickle Cell Disease Burden and Challenges in Sub-Saharan Africa.
Obi Peter Adigwe et al. J Blood Med 2023 14367-376
Significant haemoglobinopathies: A guideline for screening and diagnosis: A British Society for Haematology Guideline: A British Society for Haematology Guideline.
Barbara J Bain et al. Br J Haematol 2023 201(6) 1047-1065
Distributional Cost-Effectiveness of Equity-Enhancing Gene Therapy in Sickle Cell Disease in the United States.
George Goshua et al. Ann Intern Med 2023
TOP